Sign in Create account

Sharma East India Hospitals And Res

Healthcare · Healthcare Services

BSE: 524548
₹88.00
▲ 2.70 (3.17%)
Sept. 30, 2026 · BSE · bse_bhavcopy
Quality
42/100
Moderate
Valuation
60/100
Fairly Valued
Momentum
29/100
Bearish

QVM read Mixed signals Quality Moderate, Valuation Fairly Valued, Momentum Bearish

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹29 Cr
PE (TTM)
24.4
Industry median 50.2 (44 companies)
Price to Book
2.1
PEG (TTM)
-22.2
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
Data unavailable.
Relative return vs Sector, qtr %
8.1
Free Cash Flow
₹-5 Cr
as of March 31, 2026
Industry median ₹1 Cr (75 companies)
EPS Growth (YoY)
-18.56%
as of June 30, 2026
Industry median 13.27% (57 companies)
Net Profit Growth (TTM)
-7.86%
as of June 30, 2026
Industry median 7.21% (57 companies)
Operating Revenue Growth (TTM)
11.58%
as of June 30, 2026
Industry median 12.82% (57 companies)
Profit Growth (YoY)
-38.19%
as of Dec. 31, 2025
Industry median 8.53% (57 companies)
Revenue Growth (YoY)
13.63%
as of June 30, 2026
Industry median 18.84% (52 companies)
Current Ratio
1.11
as of March 31, 2026
Industry median 2.06 (74 companies)
Debt to Equity
0.53
as of March 31, 2026
Industry median 0.11 (62 companies)
Interest Coverage
3.54
as of June 30, 2026
Industry median 7.94 (57 companies)
Net Margin
1.85%
as of Dec. 31, 2025
Industry median 9.88% (61 companies)
Operating Margin (EBIT)
5.01%
as of June 30, 2026
Industry median 17.21% (61 companies)
Operating Margin (TTM)
5.57%
as of June 30, 2026
Industry median 16.20% (59 companies)
Return on Assets
3.35%
as of March 31, 2026
Industry median 5.40% (58 companies)
Return on Capital Employed
14.25%
as of March 31, 2026
Industry median 10.44% (56 companies)
Return on Equity
8.03%
as of March 31, 2026
Industry median 10.16% (58 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

1 of 6 met
  • No Revenue is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • No Debt to equity is below 0.5 (0.53)
  • No Return on equity is 15% or more (8.0%)
  • Yes Net cash flow for the latest year is positive
  • No Cash from operations is higher than the year before

Ownership

2 of 2 met
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

1 of 3 met
  • Yes 1-year return beats the industry median
  • No Revenue growth beats the industry median
  • No Profit growth beats the industry median

Value and momentum

0 of 5 met
  • No Price sits in the Buy zone of its own historical PE range (Sell Zone)
  • No Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
3.2%
Low 86.0000 · High 90.0000
1W return
1.3%
Low 84.0000 · High 92.0000
1M return
-6.6%
Low 84.0000 · High 100.0000
52W return
5.4%
Low 84.0000 · High 105.9500
Lifetime High ₹100.7300 (Aug. 7, 2026)
Lifetime Low ₹23.6200 (July 4, 2024)

Full price history and technicals →

Technicals

Full technicals, indicators & Volume/Delivery →

EMA & SMA

Bullish1
Bearish2
5D
87.1
10D
88.1
20D
89.1

Delivery and volume

Day avg. delivery
97.3%
Week avg. delivery
95.8%
Month avg. delivery
93.6%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

88.00
Pivot
First resistance90.00
Second resistance92.00
Third resistance94.00
First support86.00
Second support84.00
Third support82.00
Day RSI57.8
Day MFI25.2
Day MACD-0.64
Day MACD signal0.31

Beta

1M-0.42
3M-0.88
1Y-0.88
3Y-0.81

Price change analysis

↓ -6.6%
Over 1 Month
LowHigh
84.00100.00
↑ 5.4%
Over 3 Months
LowHigh
84.00105.95
↑ 5.4%
Over 6 Months
LowHigh
84.00105.95
↑ 5.4%
Over 1 Year
LowHigh
84.00105.95
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →
Current PE 24.4 (own history: 9.4–29.8)
Sell Zone

Financials

View full financials, peers & valuation multiples →
Revenue (June 30, 2026)
₹11 Cr
Net profit (June 30, 2026)
₹— Cr
Basic EPS (June 30, 2026)
₹0.7900

Ranks #50 of 62 in Healthcare Services by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter53.63%

Largest holders

Data unavailable.

Historical promoter holding

Promoters holdings were unchanged at 53.63% in Jun 2026 qtr

All shareholding details →

Corporate Announcements

All 3 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
1 Oct 2026 AGM/EGM Sharma East India Hospitals & Medical Research Ltd - 524548 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
30 Sep 2026 AGM/EGM Sharma East India Hospitals & Medical Research Ltd - 524548 - Shareholder Meeting / Postal Ballot-Outcome of AGM
29 Sep 2026 Insider Trading / SAST Sharma East India Hospitals & Medical Research Ltd - 524548 - Closure of Trading Window

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

Data unavailable.

Weaknesses

  • Low Return on Equity (8.0%)
  • Thin net profit margin (1.9%)
  • Declining profit YoY (-38.2%)

Opportunities

Data unavailable.

Threats

Data unavailable.

Board of directors and corporate information →

F&O

View F&O, Options & Backtest →

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Sharma East India Hospitals And Res

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.